Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Shandong University, Jinan 250012, China.
Department of Pharmacy, The First Affiliated Hospital of Shandong First Medical University, Jinan 250014, China.
J Chromatogr B Analyt Technol Biomed Life Sci. 2020 May 1;1144:122081. doi: 10.1016/j.jchromb.2020.122081. Epub 2020 Mar 29.
Antimicrobial activity of cefoperazone, a high protein bound cephalosporin, depends on its unbound concentration. However, the protein binding data of cefoperazone in children is limited, making it challenging to optimize antimicrobial therapy in pediatric clinical practice. Furthermore, a validated method to measure the free part in children is unavailable with the small volume of samples that can be obtained. Therefore, in the present study, we developed and validated an LC-MS/MS method for the determination of free cefoperazone in children. In this study, 70 μL of plasma was used to prepare the ultrafiltrate (only containing the free drug). Chromatographic separation of the analyte was achieved on a C18 column using gradient elution with a mobile phase of acetonitrile and water (0.1% formic acid). Negative electrospray ionisation in the multiple reaction monitoring mode was applied for the detection of cefoperazone and ceftiofur (internal standard). The calibration curve was prepared in the range of 5-5000 ng/mL with excellent linearity. For each level of quality control samples, the intra- and inter-day precision (CV) was below 9.0%, and the accuracy ranged from 91.5% to 105.0%. The matrix effect was less than 11.7%, and the recovery was between 92.9% and 95.9% of cefoperazone. The validated method has been successfully applied to the determination of free plasma concentration of cefoperazone in pediatric patients. The results of the unbound fraction showed considerable individual variability (range: 8.1-48.0%). The correlation analysis showed that age and albumin had significant effects on the protein binding of cefoperazone.
头孢哌酮是一种与蛋白高度结合的头孢菌素,其抗菌活性取决于游离浓度。然而,头孢哌酮在儿童中的蛋白结合数据有限,这使得在儿科临床实践中优化抗菌治疗具有挑战性。此外,由于可获得的样本量较小,因此缺乏用于测量儿童游离部分的验证方法。因此,在本研究中,我们开发并验证了一种用于测定儿童游离头孢哌酮的 LC-MS/MS 方法。在这项研究中,使用 70μL 血浆来制备超滤物(仅包含游离药物)。采用 C18 柱,以乙腈和水(0.1%甲酸)为流动相进行梯度洗脱,实现了分析物的色谱分离。采用负离子电喷雾多反应监测模式进行头孢哌酮和头孢噻呋(内标)的检测。校准曲线的制备范围为 5-5000ng/mL,具有良好的线性。对于每个质控样品水平,日内和日间精密度(CV)均低于 9.0%,准确度范围为 91.5%至 105.0%。基质效应小于 11.7%,头孢哌酮的回收率在 92.9%至 95.9%之间。该验证方法已成功应用于测定儿科患者游离血浆中头孢哌酮的浓度。未结合分数的结果显示出相当大的个体变异性(范围:8.1-48.0%)。相关性分析表明,年龄和白蛋白对头孢哌酮的蛋白结合有显著影响。